Literature DB >> 29868908

The Major Surface Glycoprotein of Pneumocystis murina Does Not Activate Dendritic Cells.

Monica Sassi1, Geetha Kutty1, Gabriela A Ferreyra1, Lisa R Bishop1, Yueqin Liu1, Ju Qiu2, Da Wei Huang3, Joseph A Kovacs1.   

Abstract

The major surface glycoprotein (Msg) is the most abundant surface protein among Pneumocystis species. Given that Msg is present on both the cyst and trophic forms of Pneumocystis and that dendritic cells play a critical role in initiating host immune responses, we undertook studies to examine activation of bone marrow-derived myeloid dendritic cells by Msg purified from Pneumocystis murina. Incubation of dendritic cells with Msg did not lead to increased expression of CD40, CD80, CD86, or major histocompatibility complex class II or to increased secretion of any of 10 cytokines. Microarray analysis identified very few differentially expressed genes. In contrast, lipopolysaccharide-activated dendritic cells had positive results of all of these assays. However, Msg did bind to mouse mannose macrophage receptor and human DC-SIGN, 2 C-type lectins expressed by dendritic cells that are important in recognition of pathogen-associated high-mannose glycoproteins. Deglycosylation of Msg demonstrated that this binding was dependent on glycosylation. These studies suggest that Pneumocystis has developed a mechanism to avoid activation of dendritic cells, potentially by the previously identified loss of genes that are responsible for the high level of protein mannosylation found in other fungi.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29868908      PMCID: PMC6173571          DOI: 10.1093/infdis/jiy342

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

2.  Interaction of Pneumocystis carinii with dendritic cells and resulting host responses to P. carinii.

Authors:  Hiroyasu Kobayashi; Stefan Worgall; Timothy P O'Connor; Ronald G Crystal
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

3.  A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.

Authors:  J Shellito; V V Suzara; W Blumenfeld; J M Beck; H J Steger; T H Ermak
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 4.  Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.

Authors:  Sandra J van Vliet; Juan J García-Vallejo; Yvette van Kooyk
Journal:  Immunol Cell Biol       Date:  2008-08-05       Impact factor: 5.126

5.  Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response.

Authors:  S A Theus; A G Smulian; P Steele; M J Linke; P D Walzer
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

6.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.

Authors:  F Gigliotti; J A Wiley; A G Harmsen
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

8.  Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.

Authors:  Joseph A Kovacs; Henry Masur
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272

9.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Increasing Pneumocystis pneumonia, England, UK, 2000-2010.

Authors:  Rishma Maini; Katherine L Henderson; Elizabeth A Sheridan; Theresa Lamagni; Gordon Nichols; Valerie Delpech; Nick Phin
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

View more
  5 in total

1.  Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.

Authors:  Theodore J Kottom; Deanne M Hebrink; Eva M Carmona; Andrew H Limper
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

2.  Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Additional C-type lectin receptors mediate interactions with Pneumocystis organisms and major surface glycoprotein.

Authors:  Theodore J Kottom; Eva M Carmona; Kyle Schaefbauer; Andrew H Limper
Journal:  J Med Microbiol       Date:  2021-12       Impact factor: 2.472

Review 4.  Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Pneumocystis Innate Immunity.

Authors:  Theodore J Kottom; Eva M Carmona; Andrew H Limper
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

5.  Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina.

Authors:  Theodore J Kottom; Kyle Schaefbauer; Eva M Carmona; Andrew H Limper
Journal:  Pathogens       Date:  2021-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.